3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Other hematologic neoplasm
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Hematologic Neoplasms
2
Neoplasm Metastasis
1
Interventions
Leucovorin
4
venetoclax
3
Specimen Handling
3
Fluorouracil
3
Doxorubicin
3
Cytarabine
3
Cyclophosphamide
3
Bevacizumab
3
trametinib
2
pembrolizumab
2
dabrafenib
2
Taxes
2
Sorafenib
2
Oxaliplatin
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Interleukin-2
2
Gemcitabine
2
Daunorubicin
2
Carboplatin
2
Bortezomib
2
Biopsy
2
Azacitidine
2
Albumin-Bound Paclitaxel
2
vactosertib
1
temsirolimus
1
ruxolitinib
1
romidepsin
1
regorafenib
1
ponatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Patient Navigation
×
Other hematologic neoplasm
×
Clear all
NCT04960787
2026-05-14
CREDIT
SWOG Cancer Research Network
Phase NA
Active not recruiting
331 enrolled